Role of Magnetic Resonance and Intravascular Magnetic Resonance in the Detection of Vulnerable Plaques

Journal of the American College of Cardiology

Volumn 47, Issue 8 SUPPL., 2006, Pages

  Wilensky, Robert L ^a   Song, Hee Kwon ^a   Ferrari, Victor A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY; EVALUATION; HIGH RISK POPULATION; HUMAN; LIPID ANALYSIS; MOLECULAR PROBE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; ANIMAL; ATHEROSCLEROSIS; CORONARY ARTERY ATHEROSCLEROSIS; HEART CATHETERIZATION; INTERVENTIONAL RADIOLOGY; MAGNETIC RESONANCE ANGIOGRAPHY; METHODOLOGY;

CONTRAST MEDIUM; NANOMATERIAL;

ANIMALS; ATHEROSCLEROSIS; CONTRAST MEDIA; CORONARY ARTERIOSCLEROSIS; HEART CATHETERIZATION; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; NANOSTRUCTURES; RADIOLOGY, INTERVENTIONAL;

EID: 33646057404     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.11.048     Document Type: Review

References (45)

1. Yuan C., Lin E., Millard J., and Hwang J.N. Closed contour edge detection of blood vessel lumen and outer wall boundaries in black-blood MR images. Magn Reson Imaging 17 (1999) 257-266
2. Fuster V., Corti R., Fayad Z.A., Schwitter J., and Badimon J.J. Integration of vascular biology and magnetic resonance imaging in the understanding of atherothrombosis and acute coronary syndromes. J Thromb Haemost 1 (2003) 1410-1421
3. Omary R.A., Green J.D., Schirf B.E., Li Y., Finn J.P., and Li D. Real-time magnetic resonance imaging-guided coronary catheterization in swine. Circulation 107 (2003) 2656-2659
4. Wang Y., Rossman P.J., Grimm R.C., Riederer S.J., and Ehman R.L. Navigator-echo-based real-time respiratory gating and triggering for reduction of respiration effects in three-dimensional coronary MR angiography. Radiology 198 (1996) 55-60
5. Yang P.C., Kerr A.B., Liu A.C., et al. New real-time interactive cardiac magnetic resonance imaging system complements echocardiography. J Am Coll Cardiol 32 (1998) 2049-2056
6. Fayad Z.A., Fuster V., Fallon J.T., et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 102 (2000) 506-510
7. Botnar R.M., Stuber M., Lamerichs R., et al. Initial experiences with in vivo right coronary artery human MR vessel wall imaging at 3 Tesla. J Cardiovasc Magn Reson 5 (2003) 589-594
8. Ruff J., Wiesmann F., Lanz T., and Haase A. Magnetic resonance imaging of coronary arteries and heart valves in a living mouse. techniques and preliminary results. J Magn Reson 146 (2000) 290-296
9. Martin A.J., Gotlieb A.I., and Henkelman R.M. High-resolution MR imaging of human arteries. J Magn Reson Imaging 5 (1995) 93-100
10. Toussaint J.F., Southern J.F., Fuster V., and Kantor H.L. T2-weighted contrast for NMR characterization of human atherosclerosis. Arterioscler Thromb Vasc Biol 15 (1995) 1533-1542
11. Yuan C., Mitsumori L.M., Beach K.W., and Maravilla K.R. Carotid atherosclerotic plaque. noninvasive MR characterization and identification of vulnerable lesions. Radiology 221 (2001) 285-299
12. Kampshulte A., Ferguson M.S., Kerwin W.S., et al. Differentiation of intraplaque versus juxtaluminal hemorrhage/thrombus in advanced human carotid atherosclerotic lesions by in vivo magnetic resonance imaging. Circulation 110 (2004) 3239-3244
13. Correia L.C., Atalar E., Kelemen M.D., et al. Intravascular magnetic resonance imaging of aortic atherosclerotic plaque composition. Arterioscler Thromb Vasc Biol 17 (1997) 3626-3632
14. Rogers W.J., Prichard J.W., Hu Y.L., et al. Characterization of signal properties in atherosclerotic plaque components by intravascular MRI. Arterioscler Thromb Vasc Biol 20 (2000) 1824-1830
15. McConnell M.V., Aikawa M., Maier S.E., Ganz P., Libby P., and Lee R.T. MRI of rabbit atherosclerosis in response to dietary cholesterol lowering. Arterioscler Thromb Vasc Biol 19 (1999) 1956-1959
16. Helft G., Worthley S.G., Fuster V., et al. Progression and regression of atherosclerotic lesions. monitoring with serial noninvasive magnetic resonance imaging. Circulation 105 (2002) 993-998
17. Corti R., Osende J.I., Fallon J.T., et al. The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis. J Am Coll Cardiol 43 (2004) 464-473
18. Fayad Z.A., Fuster V., Fallon J.T., et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 102 (2000) 506-510
19. Botnar R.M., Stuber M., Kissinger K.V., Kim W.Y., Spuentrup E., and Manning W.J. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation 102 (2000) 2582-2587
20. Corti R., Fayad Z.A., Fuster V., et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions. a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 104 (2001) 249-252
21. Corti R., Fuster V., Fayad Z.A., et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions. two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 106 (2002) 2884-2887
22. Zhao X.Q., Yuan C., Hatsukami T.S., et al. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI. a case-control study. Arterioscler Thromb Vasc Biol 21 (2001) 1623-1629
23. Lima J.A.C., Desai M.Y., Steen H., Warren W.P., Gautam S., and Lai S. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation 110 (2004) 2336-2341
24. Yuan C., Kerwin W.S., Ferguson M.S., et al. Contrast-enhanced high-resolution MRI for carotid artery tissue characterization. J Magn Reson Imaging 15 (2002) 62-67
25. Wasserman B.A., Smith W.I., Trout III H.H., et al. Carotid artery atherosclerosis. in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging-initial results. Radiology 223 (2002) 566-573
26. Kerwin W., Hooker A., Spilker M., et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 107 (2003) 851-856
27. Kramer C.M., Cerilli L.A., Hagspiel K., DiMaria J.M., Epstein F.H., and Kern J.A. Magnetic resonance imaging identifies the fibrous cap in atherosclerotic abdominal aortic aneurysm. Circulation 109 (2004) 1016-1021
28. Aquinaldo J.G.S., Itskovich V.V., Sirol M., et al. Atherosclerotic plaque imaging using a novel contrast agent gadofluorine M. (abstr). Mol Imaging 2 (2002) s282
29. Barkhausen J., Ebert W., Heyer C., Debatin J.F., and Weinmann H.J. Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging. Circulation 108 (2003) 605-609
30. Sirol M., Itskovich V.V., Mani V., et al. Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging. Circulation 109 (2004) 2890-2896
31. Litovsky S., Madjid M., Zarrabi A., Casscells S.W., Willerson J.T., and Naghavi M. Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo. enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma. Circulation 107 (2003) 1545-1549
32. Ruehm S.G., Corot C., Vogt P., Kolb S., and Debatin J.F. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103 (2001) 415-422
33. Kooi M.E., Cappendijk V.C., Cleutjens K.B., et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107 (2003) 2453-2458
34. Li H., Gray B.D., Corbin I., et al. MR and fluorescent imaging of low-density lipoprotein receptors. Acad Radiol 11 (2004) 1251-1259
35. Frias J.C., Williams K.J., Fisher E.A., and Fayad Z.A. Recombinant HDL-like nanoparticles. a specific contrast agent for MRI of atherosclerotic plaques. J Am Chem Soc 126 (2004) 16316-16317
36. Morawski A.M., Winter P.M., Crowder K.C., et al. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med 51 (2004) 480-486
37. 3-integrin-targeted nanoparticles. Circulation 108 (2003) 2270-2274
38. 3-targeted nanoparticles. Magn Reson Med 44 (2000) 433-439
39. Voros S., Blackman B.R., Pan D., Meyer C.H., Sarembock I.J., and Rogers W.J. Detection of VCAM-1 expression on activated endothelial cells by magnetic resonance immunohistochemistry using targeted iron nanoparticles. (abstr). Circulation 110 Suppl III (2004) 686
40. Botnar R.M., Perez A.S., Witte S., et al. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 109 (2004) 2023-2029
41. Winter P.M., Caruthers S.D., Yu X., et al. Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med 50 (2003) 411-416
42. Fayad Z.A., Aguinaldo J.G., Graham P.B., et al. Detection of arterial thrombi in vivo by MRI using a fibrin-targeted contrast agent (abstr). Circulation 106 Suppl II (2002) 435
43. Toussaint J.F., Southern J.F., Fuster V., and Kantor H.L. Water diffusion properties of human atherosclerosis and thrombosis measured by pulse field gradient nuclear magnetic resonance. Arterioscler Thromb Vasc Biol 17 (1997) 542-546
44. Blank A., Alexandrowicz G., Muchnik L., et al. Miniature self-contained NMR probe for clinical applications. Magn Reson Med 54 (2005) 105-112
45. Schneiderman J., Wilensky R.L., Weiss A., et al. Diagnosis of thin-cap fibroatheromas by a self-contained intravascular magnetic resonance imaging probe in ex vivo human aortas and in situ coronary arteries. J Am Coll Cardiol 45 (2005) 1961-1969